| Awakening the “guardian of genome”: reactivation of mutant p53 A Binayke, S Mishra, P Suman, S Das, H Chander Cancer chemotherapy and pharmacology 83, 1-15, 2019 | 46 | 2019 |
| SNPs in miRNAs and target sequences: role in cancer and diabetes Y Chhichholiya, AK Suryan, P Suman, A Munshi, S Singh Frontiers in Genetics 12, 793523, 2021 | 25 | 2021 |
| High expression of FBP17 in invasive breast cancer cells promotes invadopodia formation P Suman, S Mishra, H Chander Medical Oncology 35 (5), 71, 2018 | 20 | 2018 |
| The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies Y Chhichholiya, P Suman, S Singh, A Munshi Medical Oncology 38 (8), 95, 2021 | 11 | 2021 |
| High formin binding protein 17 (FBP17) expression indicates poor differentiation and invasiveness of ductal carcinomas P Suman, S Mishra, H Chander Scientific reports 10 (1), 11543, 2020 | 9 | 2020 |
| High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues V Mehta, P Suman, H Chander Clinical and Translational Oncology 24 (12), 2351-2365, 2022 | 8 | 2022 |
| Long non-coding RNAs involved in different steps of cancer metastasis P Suman, Y Chhichholiya, P Kaur, S Ghosh, A Munshi Clinical and Translational Oncology 24 (6), 997-1013, 2022 | 8 | 2022 |
| Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion P Suman, V Mehta, AWB Craig, H Chander Carcinogenesis 43 (5), 494-503, 2022 | 4 | 2022 |
| Assessment and identification of bioactive metabolites from terrestrial Lyngbya spp. responsible for antioxidant, antifungal, and anticancer activities S Verma, P Suman, S Mandal, R Kumar, N Sahana, N Siddiqui, ... Brazilian Journal of Microbiology 54 (4), 2671-2687, 2023 | 1 | 2023 |
| Krüppel-like factors in regulation of gastric cancer progression S Kakkat, P Suman, S Goswami, S Basu, MJ Heslin, EA Turbat-Herrera, ... Cancer Research 84 (6_Supplement), 3034-3034, 2024 | | 2024 |
| Role of WNK1 in extracellular matrix modification in breast cancer P Suman, S Kakkat, SS Patil, V Ramirez, EA Turbat-Herrera, S Singh, ... Cancer Research 84 (6_Supplement), 4278-4278, 2024 | | 2024 |
| Abstract 1757 Investigating the effect of WNK lysine deficient protein kinase inhibition in breast cancer S Patil, P Suman, S Kakkat, E Turbat-Herrera, S Singh, C Sarkar, ... Journal of Biological Chemistry 300 (3), 2024 | | 2024 |
| Design, Synthesis, and Anticancer Evaluation of Hemithioindigos via Inhibition of Human Topoisomerases M Kaur, P Suman, S Arora, T Singh, A Munshi, S Singh, R Kumar ChemistrySelect 8 (41), e202301700, 2023 | | 2023 |
| Natural Compound-Based Nanoparticles to Target Free Radicals in Cancer UP Yadav, M Rhuthuparna, K Vasudev, P Suman, A Munshi, S Kumar, ... Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, 1-14, 2022 | | 2022 |
| Transcriptional Regulation of Pro-metastatic Protein Formin Binding Protein17 (FBP17) in Breast Cancer P Suman Central University of Punjab, 2018 | | 2018 |
| HUMAN INTERFERON REGULATORY FACTOR-2 (IRF-2): CHIMERIC PROTEIN AND EXPRESSION ANALYSIS Santosh Kumar Mishra, Prabhat Suman, Pushpa Kumari Sharma, Nitish Kumar and ... IJBPAS 4 (9), 5990-6002, 2015 | | 2015 |
Harish ChanderNational Institute of Biologicals, IndiaVerified email at queensu.ca
